Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 January 2008, Vol. 111, No. 1, pp. 165-174.
Prepublished online as a Blood First Edition Paper on September 11, 2007; DOI 10.1182/blood-2007-04-086983.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2007-04-086983v1
111/1/165    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gardiner, E. E
Right arrow Articles by Berndt, M. C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gardiner, E. E
Right arrow Articles by Berndt, M. C
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted April 24, 2007
Accepted August 24, 2007

Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: De-ITAM-ising Fc{gamma}RIIa

Elizabeth E Gardiner, Denuja Karunakaran, Jane F. Arthur, Fi-Tjen Mu, Maree S Powell, Ross I Baker, P Mark Hogarth, Mark L Kahn, Robert K Andrews, and Michael C Berndt*

Department of Immunology, Monash University, Melbourne, Australia
The Burnet Institute, Melbourne, Australia
Haemophilia Centre of Western Australia, Royal Perth Hospital, & Dept of Medicine & Pharmacology, University of Western Australia, Perth, Australia
Department of Medicine, University of Pennsylvania, Philadelphia, PA, United States

* Corresponding author; email: michael.berndt{at}med.monash.edu.au.

Collagen binding to glycoprotein (GP)VI induces signals critical for platelet activation in thrombosis. Both ligand-induced GPVI signaling through its co-associated Fc-receptor {gamma}-chain (FcR{gamma}) immunoreceptor tyrosine-activation motif (ITAM), and the calmodulin inhibitor, W7, dissociate calmodulin from GPVI and induce metalloproteinase-mediated GPVI ectodomain shedding. We investigated whether signaling via another ITAM-bearing receptor on platelets, Fc{gamma}RIIa, also downregulates GPVI expression. Agonists that signal through Fc{gamma}RIIa, the mAbs VM58 or 14A2, potently induced GPVI shedding, inhibitable by the metalloproteinase inhibitor, GM6001. Unexpectedly, Fc{gamma}RIIa also underwent rapid proteolysis in platelets treated with agonists for Fc{gamma}RIIa (VM58/14A2) or GPVI/FcR{gamma} (the snake toxin, convulxin), generating an ~30-kDa fragment. Immunoprecipitation/pull-down experiments showed Fc{gamma}RIIa also bound calmodulin and W7 induced Fc{gamma}RIIa cleavage. However, unlike GPVI, the ~30-kDa Fc{gamma}RIIa fragment remained platelet-associated, and proteolysis was unaffected by GM6001, but inhibited by a membrane-permeable calpain inhibitor, E64d; consistent with this, µ-calpain cleaved an Fc{gamma}RIIa tail-fusion protein at 222Lys/223Ala and 230Gly/231Arg, upstream of the ITAM domain. These findings suggest simultaneous activation of distinct extracellular (metalloproteinase-mediated) and intracellular (calpain-mediated) proteolytic pathways irreversibly inactivating platelet GPVI/FcR{gamma} and Fc{gamma}RIIa, respectively. Activation of both pathways was observed with immunoglobulin from heparin-induced thrombocytopenia (HIT) patients, suggesting novel mechanisms for platelet dysfunction via Fc{gamma}RIIa following immunological insult.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Braking platelet activation: deactivating the receptors
Koneti A. Rao
Blood 2008 111: 3. [Full Text] [PDF]



This article has been cited by other articles:


Home page
JEMHome page
H. Kubagawa, S. Oka, Y. Kubagawa, I. Torii, E. Takayama, D.-W. Kang, G. L. Gartland, L. F. Bertoli, H. Mori, H. Takatsu, et al.
Identity of the elusive IgM Fc receptor (Fc{micro}R) in humans
J. Exp. Med., November 23, 2009; 206(12): 2779 - 2793.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Boylan, C. Gao, V. Rathore, J. C. Gill, D. K. Newman, and P. J. Newman
Identification of Fc{gamma}RIIa as the ITAM-bearing receptor mediating {alpha}IIb{beta}3 outside-in integrin signaling in human platelets
Blood, October 1, 2008; 112(7): 2780 - 2786.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020